Intranasal delivery bypasses the blood-brain barrier to target therapeutics to the brain to improve memory in humans with Alzheimer's disease and treat neurological and psychiatric disorders in animal models
Overview
authors
Frey II, William H., PhD
publication date
2007
Research
keywords
Alzheimer's Disease
Animal
Drugs
Intranasal Administration
Models
Therapy